The Interaction Pattern of Murine Serum Ficolin-A with Microorganisms

Overview

Journal PLoS One

Specialties General Medicine
Science

Date 2012 Jun 6

PMID 22666482

Citations 17

Authors

Tina Hummelshoj

Ying Jie Ma

Lea Munthe-Fog

Thomas Bjarnsholt

Claus Moser

Mikkel-Ole Skjoedt

Luigina Romani

Teizo Fujita

Yuichi Endo

Peter Garred

Affiliations

Soon will be listed here.

Abstract

The ficolins are soluble pattern recognition molecules in the lectin pathway of complement, but the spectrum and mode of interaction with pathogens are largely unknown. In this study, we investigated the binding properties of the murine serum ficolin-A towards a panel of different clinical relevant microorganisms (N = 45) and compared the binding profile with human serum ficolin-2 and ficolin-3. Ficolin-A was able to bind Gram-positive bacteria strains including E. faecalis, L. monocytogenes and some S. aureus strains, but not to the investigated S. agalactiae (Group B streptococcus) strains. Regarding Gram-negative bacteria ficolin-A was able to bind to some E. coli and P. aeruginosa strains, but not to the investigated Salmonella strains. Of particular interest ficolin-A bound strongly to the pathogenic E. coli, O157:H7 and O149 strains, but it did not bind to the non-pathogenic E. coli, ATCC 25922 strain. Additionally, ficolin-A was able to bind purified LPS from these pathogenic strains. Furthermore, ficolin-A bound to a clinical isolate of the fungus A. fumigatus. In general ficolin-2 showed similar selective binding spectrum towards pathogenic microorganisms as observed for ficolin-A indicating specific pathophysiological roles of these molecules in host defence. In contrast, ficolin-3 did not bind to any of the investigated microorganisms and the anti-microbial role of ficolin-3 still remains elusive.

Citing Articles

Interplay between host humoral pattern recognition molecules controls undue immune responses against Aspergillus fumigatus.

Delliere S, Chauvin C, Wong S, Gressler M, Possetti V, Parente R Nat Commun. 2024; 15(1):6966.

PMID: 39138196 PMC: 11322389. DOI: 10.1038/s41467-024-51047-9.

Protective role of host complement system in infection.

Shende R, Wong S, Meitei H, Lal G, Madan T, Aimanianda V Front Immunol. 2022; 13:978152.

PMID: 36211424 PMC: 9539816. DOI: 10.3389/fimmu.2022.978152.

Capsule type defines the capability of Klebsiella pneumoniae in evading Kupffer cell capture in the liver.

Huang X, Li X, An H, Wang J, Ding M, Wang L PLoS Pathog. 2022; 18(8):e1010693.

PMID: 35914009 PMC: 9342791. DOI: 10.1371/journal.ppat.1010693.

Functional vulnerability of liver macrophages to capsules defines virulence of blood-borne bacteria.

An H, Qian C, Huang Y, Li J, Tian X, Feng J J Exp Med. 2022; 219(4).

PMID: 35258552 PMC: 8908791. DOI: 10.1084/jem.20212032.

Ficolins and the Recognition of Pathogenic Microorganisms: An Overview of the Innate Immune Response and Contribution of Single Nucleotide Polymorphisms.

Bidula S, Sexton D, Schelenz S J Immunol Res. 2019; 2019:3205072.

PMID: 30868077 PMC: 6379837. DOI: 10.1155/2019/3205072.

References

Aoyagi Y, Adderson E, Rubens C, Bohnsack J, Min J, Matsushita M . L-Ficolin/mannose-binding lectin-associated serine protease complexes bind to group B streptococci primarily through N-acetylneuraminic acid of capsular polysaccharide and activate the complement pathway. Infect Immun. 2007; 76(1):179-88. PMC: 2223634. DOI: 10.1128/IAI.00837-07. View

Fujita T, Matsushita M, Endo Y . The lectin-complement pathway--its role in innate immunity and evolution. Immunol Rev. 2004; 198:185-202. DOI: 10.1111/j.0105-2896.2004.0123.x. View

Gaziano R, Bozza S, Bellocchio S, Perruccio K, Montagnoli C, Pitzurra L . Anti-Aspergillus fumigatus efficacy of pentraxin 3 alone and in combination with antifungals. Antimicrob Agents Chemother. 2004; 48(11):4414-21. PMC: 525434. DOI: 10.1128/AAC.48.11.4414-4421.2004. View

Sallenbach S, Thiel S, Aebi C, Otth M, Bigler S, Jensenius J . Serum concentrations of lectin-pathway components in healthy neonates, children and adults: mannan-binding lectin (MBL), M-, L-, and H-ficolin, and MBL-associated serine protease-2 (MASP-2). Pediatr Allergy Immunol. 2011; 22(4):424-30. DOI: 10.1111/j.1399-3038.2010.01104.x. View

Endo Y, Matsushita M, Fujita T . The role of ficolins in the lectin pathway of innate immunity. Int J Biochem Cell Biol. 2011; 43(5):705-12. DOI: 10.1016/j.biocel.2011.02.003. View

Kjaer T, Hansen A, Sorensen U, Nielsen O, Thiel S, Jensenius J . Investigations on the pattern recognition molecule M-ficolin: quantitative aspects of bacterial binding and leukocyte association. J Leukoc Biol. 2011; 90(3):425-37. DOI: 10.1189/jlb.0411201. View

Garlatti V, Belloy N, Martin L, Lacroix M, Matsushita M, Endo Y . Structural insights into the innate immune recognition specificities of L- and H-ficolins. EMBO J. 2007; 26(2):623-33. PMC: 1783469. DOI: 10.1038/sj.emboj.7601500. View

Lynch N, Roscher S, Hartung T, Morath S, Matsushita M, Maennel D . L-ficolin specifically binds to lipoteichoic acid, a cell wall constituent of Gram-positive bacteria, and activates the lectin pathway of complement. J Immunol. 2004; 172(2):1198-202. DOI: 10.4049/jimmunol.172.2.1198. View

Roberts I . The biochemistry and genetics of capsular polysaccharide production in bacteria. Annu Rev Microbiol. 1996; 50:285-315. DOI: 10.1146/annurev.micro.50.1.285. View

10.

Ma Y, Doni A, Hummelshoj T, Honore C, Bastone A, Mantovani A . Synergy between ficolin-2 and pentraxin 3 boosts innate immune recognition and complement deposition. J Biol Chem. 2009; 284(41):28263-28275. PMC: 2788878. DOI: 10.1074/jbc.M109.009225. View

11.

Gout E, Garlatti V, Smith D, Lacroix M, Dumestre-Perard C, Lunardi T . Carbohydrate recognition properties of human ficolins: glycan array screening reveals the sialic acid binding specificity of M-ficolin. J Biol Chem. 2009; 285(9):6612-22. PMC: 2825457. DOI: 10.1074/jbc.M109.065854. View

12.

Hummelshoj T, Thielens N, Madsen H, Arlaud G, Sim R, Garred P . Molecular organization of human Ficolin-2. Mol Immunol. 2006; 44(4):401-11. DOI: 10.1016/j.molimm.2006.02.023. View

13.

Krarup A, Skov Sorensen U, Matsushita M, Jensenius J, Thiel S . Effect of capsulation of opportunistic pathogenic bacteria on binding of the pattern recognition molecules mannan-binding lectin, L-ficolin, and H-ficolin. Infect Immun. 2005; 73(2):1052-60. PMC: 547010. DOI: 10.1128/IAI.73.2.1052-1060.2005. View

14.

Kuraya M, Ming Z, Liu X, Matsushita M, Fujita T . Specific binding of L-ficolin and H-ficolin to apoptotic cells leads to complement activation. Immunobiology. 2005; 209(9):689-97. DOI: 10.1016/j.imbio.2004.11.001. View

15.

Tsujimura M, Miyazaki T, Kojima E, Sagara Y, Shiraki H, Okochi K . Serum concentration of Hakata antigen, a member of the ficolins, is linked with inhibition of Aerococcus viridans growth. Clin Chim Acta. 2002; 325(1-2):139-46. DOI: 10.1016/s0009-8981(02)00274-7. View

16.

Hummelshoj T, Fog L, Madsen H, Sim R, Garred P . Comparative study of the human ficolins reveals unique features of Ficolin-3 (Hakata antigen). Mol Immunol. 2007; 45(6):1623-32. DOI: 10.1016/j.molimm.2007.10.006. View

17.

Wachsmuth I, Griffin P, Wells J . Escherichia coli O157:H7, a cause of hemorrhagic colitis and hemolytic uremic syndrome. Acta Paediatr Jpn. 1991; 33(5):603-12. DOI: 10.1111/j.1442-200x.1991.tb01872.x. View

18.

Garlanda C, Hirsch E, Bozza S, Salustri A, De Acetis M, Nota R . Non-redundant role of the long pentraxin PTX3 in anti-fungal innate immune response. Nature. 2002; 420(6912):182-6. DOI: 10.1038/nature01195. View

19.

Endo Y, Liu Y, Kanno K, Takahashi M, Matsushita M, Fujita T . Identification of the mouse H-ficolin gene as a pseudogene and orthology between mouse ficolins A/B and human L-/M-ficolins. Genomics. 2004; 84(4):737-44. DOI: 10.1016/j.ygeno.2004.07.006. View

20.

Swierzko A, Lukasiewicz J, Cedzynski M, Maciejewska A, Jachymek W, Niedziela T . New functional ligands for ficolin-3 among lipopolysaccharides of Hafnia alvei. Glycobiology. 2011; 22(2):267-80. DOI: 10.1093/glycob/cwr119. View